{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:46:59Z","timestamp":1786985219577,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ataturk University","award":["2015\/078"],"award-info":[{"award-number":["2015\/078"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bioorg.2020.103627","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T19:57:09Z","timestamp":1580155029000},"page":"103627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Synthesis, structure elucidation, and in vitro pharmacological evaluation of novel polyfluoro substituted pyrazoline type sulfonamides as multi-target agents for inhibition of acetylcholinesterase and carbonic anhydrase I and II enzymes"],"prefix":"10.1016","volume":"96","author":[{"given":"Cem","family":"Yamali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halise Inci","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cavit","family":"Kazaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Levent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhami","family":"Gulcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103627_b0005","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.arcmed.2012.11.003","article-title":"Epidemiology of dementias and Alzheimer's disease","volume":"43","author":"Sosa-Ortiz","year":"2012","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.bioorg.2020.103627_b0010","unstructured":"Alzheimer\u2019s Disease International. 2019. World Alzheimer Report 2019: Attitudes to dementia. London: Alzheimer\u2019s Disease International."},{"key":"10.1016\/j.bioorg.2020.103627_b0015","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1007\/s12035-019-1563-9","article-title":"Molecular targets in Alzheimer's disease","volume":"56","author":"Bjorklund","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2020.103627_b0020","article-title":"Alzheimer's disease and its potential alternative therapeutics","volume":"9","author":"Kisby","year":"2019","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"10.1016\/j.bioorg.2020.103627_b0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/joim.12959","article-title":"Current and emerging avenues for Alzheimer's disease drug targets","volume":"286","author":"Loera-Valencia","year":"2019","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bioorg.2020.103627_b0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14283\/jpad.2018.43","article-title":"Revisiting the cholinergic hypothesis in Alzheimer's disease: emerging evidence from translational and clinical research","volume":"6","author":"Hampel","year":"2019","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.bioorg.2020.103627_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24081519","article-title":"Natural products in Alzheimer's disease therapy: would old therapeutic approaches fix the broken promise of modern medicines?","volume":"24","author":"Habtemariam","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2020.103627_b0040","first-page":"208","article-title":"Drugs for Alzheimer\u2019s disease: are they effective?","volume":"35","author":"David","year":"2010","journal-title":"Pharm. Therapeut."},{"key":"10.1016\/j.bioorg.2020.103627_b0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bioorg.2020.103627_b0055","doi-asserted-by":"crossref","unstructured":"M.A. Supuran C.T, Polypharmacology of carbonic anhydrase inhibitors, Pharmadvances, 14-38, 2019.","DOI":"10.36118\/pharmadvances.00.2019.06"},{"key":"10.1016\/j.bioorg.2020.103627_b0060","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.bmc.2017.01.031","article-title":"Carbonic anhydrases activation with 3-amino-1H-1,2,4-triazole-1-carboxamides: Discovery of subnanomolar isoform II activators","volume":"25","author":"Le Duc","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0065","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2174\/138161208783877857","article-title":"Carbonic anhydrase activation and the drug design","volume":"14","author":"Temperini","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bioorg.2020.103627_b0070","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.bmcl.2019.06.041","article-title":"Sulfonamide derivatives as multi-target agents for complex diseases","volume":"29","author":"Apaydin","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103627_b0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bioorg.2017.01.005","article-title":"Microwave assisted synthesis of novel hybrid tacrine-sulfonamide derivatives and investigation of their antioxidant and anticholinesterase activities","volume":"70","author":"Ulus","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.bioorg.2018.12.028","article-title":"Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity","volume":"84","author":"Ozmen Ozgun","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0085","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/cbdd.13149","article-title":"Synthesis, molecular modeling, and biological evaluation of 4-[5-aryl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes","volume":"91","author":"Yamali","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2020.103627_b0090","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/fmc.14.68","article-title":"Sulfonamides and their isosters as carbonic anhydrase inhibitors","volume":"6","author":"Carta","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/14756366.2016.1243536","article-title":"Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides","volume":"32","author":"Gul","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0100","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3109\/14756366.2016.1160077","article-title":"Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4-dihydro-3H-indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides","volume":"31","author":"Gul","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0105","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bioorg.2018.03.027","article-title":"Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes","volume":"78","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bioorg.2018.01.021","article-title":"New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors","volume":"77","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0115","doi-asserted-by":"crossref","first-page":"103222","DOI":"10.1016\/j.bioorg.2019.103222","article-title":"Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors","volume":"92","author":"Yamali","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0120","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2174\/1570180814666170703164221","article-title":"A comprehensive review on recent developments in the field of biological applications of potent pyrazolines derived from chalcone precursors","volume":"15","author":"Salian","year":"2018","journal-title":"Lett Drug Des Discov"},{"key":"10.1016\/j.bioorg.2020.103627_b0125","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.2174\/1871520618666180313153407","article-title":"2-Pyrazolines as biologically active and fluorescent agents","volume":"18","author":"Singh","year":"2018","journal-title":"An Overview, Anticancer Agents Med Chem"},{"key":"10.1016\/j.bioorg.2020.103627_b0130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm1235","article-title":"Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production","volume":"11","author":"Kukar","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2020.103627_b0135","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/14756360701425014","article-title":"The role of fluorine in medicinal chemistry","volume":"22","author":"Shah","year":"2007","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0140","doi-asserted-by":"crossref","first-page":"11797","DOI":"10.1002\/chem.201901840","article-title":"Fluorine-containing drugs approved by the FDA in 2018","volume":"25","author":"Mei","year":"2019","journal-title":"Chemistry"},{"key":"10.1016\/j.bioorg.2020.103627_b0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jfluchem.2018.11.002","article-title":"Recent progress in the strategic incorporation of fluorine into medicinally active compounds","volume":"217","author":"Haranahalli","year":"2019","journal-title":"J Fluor Chem"},{"key":"10.1016\/j.bioorg.2020.103627_b0150","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0155","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1021\/jm0600287","article-title":"Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX","volume":"49","author":"Thiry","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0160","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.bmcl.2004.01.095","article-title":"Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. the first subnanomolar CA IX inhibitor discovered","volume":"14","author":"Vullo","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103627_b0165","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/80800642","article-title":"Microwave-assisted synthesis of some 3,5-arylated 2-pyrazolines","volume":"8","author":"Davood Azarifar","year":"2003","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2020.103627_b0170","doi-asserted-by":"crossref","first-page":"46999","DOI":"10.1039\/C7RA08939B","article-title":"Unveiling a versatile heterocycle: pyrazoline -a review","volume":"7","author":"Varghese","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2020.103627_b0175","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bioorg.2019.03.052","article-title":"Design synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives","volume":"87","author":"Abdel-Aziz","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0180","doi-asserted-by":"crossref","first-page":"111638","DOI":"10.1016\/j.ejmech.2019.111638","article-title":"Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I II, IX and XII inhibitors: Synthesis and biological evaluation","volume":"182","author":"Moi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2020.103627_b0190","unstructured":"(https:\/\/www.molinspiration.com\/), accessed on January 2020."},{"key":"10.1016\/j.bioorg.2020.103627_b0195","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00044-017-1911-0","article-title":"Synthesis and structure elucidation of 1-(2, 5\/3, 5-difluorophenyl)-3-(2, 3\/2, 4\/2, 5\/3, 4-dimethoxyphenyl)-2-propen-1-ones as anticancer agents","volume":"26","author":"Yamali","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2020.103627_b0200","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2174\/1871520617666170327123909","article-title":"Synthesis and cytotoxic activities of difluoro-dimethoxy chalcones","volume":"17","author":"Yamali","year":"2017","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103627_b0210","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.103627_b0215","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bioorg.2016.12.001","article-title":"Synthesis, characterization, anticancer, antimicrobial and carbonic anhydrase inhibition profiles of novel (3aR,4S,7R,7aS)-2-(4-((E)-3-(3-aryl)acryloyl) phenyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione derivatives","volume":"70","author":"Kocyigit","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103627_b0220","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2020.103627_b0225","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0021-9258(18)95800-X","article-title":"Esterase activities of human carbonic anhydrases B and C","volume":"242","author":"Verpoorte","year":"1967","journal-title":"J. Biol. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819318668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819318668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:02:16Z","timestamp":1758614536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819318668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":45,"alternative-id":["S0045206819318668"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103627","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, structure elucidation, and in vitro pharmacological evaluation of novel polyfluoro substituted pyrazoline type sulfonamides as multi-target agents for inhibition of acetylcholinesterase and carbonic anhydrase I and II enzymes","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103627"}}